156 related articles for article (PubMed ID: 36751636)
21. FGF19 genetic amplification as a potential therapeutic target in lung squamous cell carcinomas.
Zhang X; Kong M; Zhang Z; Xu S; Yan F; Wei L; Zhou J
Thorac Cancer; 2017 Nov; 8(6):655-665. PubMed ID: 28906590
[TBL] [Abstract][Full Text] [Related]
22. CCNG1 (Cyclin G1) regulation by mutant-P53 via induction of Notch3 expression promotes high-grade serous ovarian cancer (HGSOC) tumorigenesis and progression.
Xu Y; Zhang Q; Miao C; Dongol S; Li Y; Jin C; Dong R; Li Y; Yang X; Kong B
Cancer Med; 2019 Jan; 8(1):351-362. PubMed ID: 30565428
[TBL] [Abstract][Full Text] [Related]
23. Metformin combined with p38 MAPK inhibitor improves cisplatin sensitivity in cisplatin‑resistant ovarian cancer.
Xie Y; Peng Z; Shi M; Ji M; Guo H; Shi H
Mol Med Rep; 2014 Nov; 10(5):2346-50. PubMed ID: 25118792
[TBL] [Abstract][Full Text] [Related]
24. Regulation of LC3-dependent protective autophagy in ovarian cancer cells by protein phosphatase 2A.
Yin X; Zhang N; Di W
Int J Gynecol Cancer; 2013 May; 23(4):630-41. PubMed ID: 23518861
[TBL] [Abstract][Full Text] [Related]
25. Induction of autophagy contributes to cisplatin resistance in human ovarian cancer cells.
Bao L; Jaramillo MC; Zhang Z; Zheng Y; Yao M; Zhang DD; Yi X
Mol Med Rep; 2015 Jan; 11(1):91-8. PubMed ID: 25322694
[TBL] [Abstract][Full Text] [Related]
26. MircroRNA-139 sensitizes ovarian cancer cell to cisplatin-based chemotherapy through regulation of ATP7A/B.
Xiao F; Li Y; Wan Y; Xue M
Cancer Chemother Pharmacol; 2018 May; 81(5):935-947. PubMed ID: 29594361
[TBL] [Abstract][Full Text] [Related]
27. shRNA-mediated AMBRA1 knockdown reduces the cisplatin-induced autophagy and sensitizes ovarian cancer cells to cisplatin.
Li X; Zhang L; Yu L; Wei W; Lin X; Hou X; Tian Y
J Toxicol Sci; 2016 Feb; 41(1):45-53. PubMed ID: 26763392
[TBL] [Abstract][Full Text] [Related]
28. Identifying novel hypoxia-associated markers of chemoresistance in ovarian cancer.
McEvoy LM; O'Toole SA; Spillane CD; Martin CM; Gallagher MF; Stordal B; Blackshields G; Sheils O; O'Leary JJ
BMC Cancer; 2015 Jul; 15():547. PubMed ID: 26205780
[TBL] [Abstract][Full Text] [Related]
29. Forkhead Box Protein C2 (FOXC2) Promotes the Resistance of Human Ovarian Cancer Cells to Cisplatin In Vitro and In Vivo.
Li C; Ding H; Tian J; Wu L; Wang Y; Xing Y; Chen M
Cell Physiol Biochem; 2016; 39(1):242-52. PubMed ID: 27336949
[TBL] [Abstract][Full Text] [Related]
30. Knockdown of BRCA2 enhances cisplatin and cisplatin-induced autophagy in ovarian cancer cells.
Wan B; Dai L; Wang L; Zhang Y; Huang H; Qian G; Yu T
Endocr Relat Cancer; 2018 Jan; 25(1):69-82. PubMed ID: 29066501
[TBL] [Abstract][Full Text] [Related]
31. Damnacanthal isolated from morinda species inhibited ovarian cancer cell proliferation and migration through activating autophagy.
Li R; Li H; Lan J; Yang D; Lin X; Xu H; Han B; Yang M; Su B; Liu F; Jiang W
Phytomedicine; 2022 Jun; 100():154084. PubMed ID: 35421676
[TBL] [Abstract][Full Text] [Related]
32. Nrf2 induced cisplatin resistance in ovarian cancer by promoting CD99 expression.
Wu J; Zhang L; Li H; Wu S; Liu Z
Biochem Biophys Res Commun; 2019 Oct; 518(4):698-705. PubMed ID: 31472965
[TBL] [Abstract][Full Text] [Related]
33. [Effect of glucose regulated protein 78 on autophagy and apoptosis in ovarian epithelial carcinoma].
Li M; Tian J; Qu Q
Zhonghua Fu Chan Ke Za Zhi; 2015 Nov; 50(11):848-53. PubMed ID: 26887774
[TBL] [Abstract][Full Text] [Related]
34. Cisplatin induces protective autophagy through activation of BECN1 in human bladder cancer cells.
Lin JF; Lin YC; Tsai TF; Chen HE; Chou KY; Hwang TI
Drug Des Devel Ther; 2017; 11():1517-1533. PubMed ID: 28553083
[TBL] [Abstract][Full Text] [Related]
35. Role of autophagy in cisplatin resistance in ovarian cancer cells.
Wang J; Wu GS
J Biol Chem; 2014 Jun; 289(24):17163-73. PubMed ID: 24794870
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA 1301 inhibits cisplatin resistance in human ovarian cancer cells by regulating EMT and autophagy.
Yu JL; Gao X
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1688-1696. PubMed ID: 32141535
[TBL] [Abstract][Full Text] [Related]
37. HIF-1α-induced autophagy contributes to cisplatin resistance in ovarian cancer cells.
Long F; Liu W; Jia P; Wang H; Jiang G; Wang T
Pharmazie; 2018 Sep; 73(9):533-536. PubMed ID: 30223937
[TBL] [Abstract][Full Text] [Related]
38. MKNK2 enhances chemoresistance of ovarian cancer by suppressing autophagy via miR-125b.
Wang J; Da C; Su Y; Song R; Bai Z
Biochem Biophys Res Commun; 2021 Jun; 556():31-38. PubMed ID: 33836345
[TBL] [Abstract][Full Text] [Related]
39. 4-Acetylantroquinonol B suppresses autophagic flux and improves cisplatin sensitivity in highly aggressive epithelial cancer through the PI3K/Akt/mTOR/p70S6K signaling pathway.
Liu M; Bamodu OA; Huang WC; Zucha MA; Lin YK; Wu ATH; Huang CC; Lee WH; Yuan CC; Hsiao M; Deng L; Tzeng YM; Yeh CT
Toxicol Appl Pharmacol; 2017 Jun; 325():48-60. PubMed ID: 28408137
[TBL] [Abstract][Full Text] [Related]
40. p62/SQSTM1 as an oncotarget mediates cisplatin resistance through activating RIP1-NF-κB pathway in human ovarian cancer cells.
Yan XY; Zhang Y; Zhang JJ; Zhang LC; Liu YN; Wu Y; Xue YN; Lu SY; Su J; Sun LK
Cancer Sci; 2017 Jul; 108(7):1405-1413. PubMed ID: 28498503
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
